Acute Respiratory Distress Syndrome (ARDS)

• A 46-year-old woman is admitted to the ICU with severe pancreatitis. During the first 24 hours of admission, severe hypoxemia that requires ventilatory support with high concentrations of inspired oxygen develop. On exam the patient has rhonchi and crackles bilaterally. An arterial blood gas collected at 60% FiO₂ reveals pH 7.42, PCO₂ 35 mmHg, and PO₂ 108 mmHg.

Introduction – Acute Respiratory Distress Syndrome

• Defined asacute diffuse, inflammatory lung injury leading to increased vascular permeability, increased lung weight and loss of aerated lung tissue 
  • hyperactivation of coagulation and/or inflammation damages both type I and II pneumocytes
    • ↓ type II pneumocytes results in ↓ surfactant production 
    • ↓ surfactant production results in low lung compliance and subsequent atelectasis
  • repair often results in interstitial fibrosis
• Causes 
  • infection
    • pneumonia
    • sepsis
      • typically gram-negative sepsis
  • aspiration
  • acute pancreatitis
  • trauma with shock
  • amniotic fluid embolism (rare)
• uremia

Presentation

• Symptoms
  • dyspnea
• Physical exam
  • tachypnea
• bilateral rales and decreased breath sounds

Evaluation

• Arterial blood gas
  • severe hypoxemia on pulse oximetry and ABG
    • may not be responsive to 100% O₂
    • atelectasis results in intrapulmonary shunting
• Radiology
  • diffuse, bilateral alveolar infiltrates on CXR
  • ground glass opacities and consolidations on chest CT often with dependent lung predominence
• Histology 
  • diffuse alveolar damage
  • protein-rich leakage (exudate) forming an intra-alveolar hyaline membrane 
• Severity graded on PaO₂ / FiO₂ ratio and required PEEP (see below)

Treatment

• Respiratory support & treat underlying cause
  • Mechanical ventilation with low tidal volume (4-6 mL/kg ideal body weight) 
  • High FiO2
  • PEEP (positive end-expiratory pressure) 
    • prevents airway collapse at end-expiration
    • recruits collapsed alveoli
      • increases FRC and decreases shunting
    • improves oxygenation 

Acute Respiratory Distress Syndrome (ARDS) is a serious condition that affects the lungs, causing fluid to build up in the air sacs, making it difficult to breathe. Treatment of ARDS aims to support respiratory function and address the underlying cause of the condition. Here are some common treatments for ARDS:

1. Oxygen therapy: Patients with ARDS may require oxygen therapy to help maintain adequate oxygen levels in the blood.
2. Mechanical ventilation: In severe cases, patients may require mechanical ventilation to help them breathe. This involves the use of a machine to deliver oxygen and remove carbon dioxide from the lungs.
3. Fluid management: Excessive fluid in the lungs can worsen ARDS, so patients may receive medication to help remove excess fluid from the body.
4. Medications: Patients with ARDS may receive medications to treat the underlying cause of the condition. For example, antibiotics may be given for bacterial infections, or corticosteroids may be given to reduce inflammation in the lungs.
5. Nutritional support: Patients with ARDS may require specialized nutrition to maintain their strength and promote healing.
6. Positioning: Patients may be placed in specific positions, such as lying on their stomach (prone position), to help improve oxygenation.
7. Extracorporeal membrane oxygenation (ECMO): In rare cases, patients with severe ARDS may require ECMO, which involves using a machine to take over the work of the lungs and heart temporarily.

Studies

There have been numerous studies conducted on Acute Respiratory Distress Syndrome (ARDS) in recent years, exploring the causes, risk factors, diagnosis, and treatment of this condition. Here are a few examples of recent studies:

1. A study published in the New England Journal of Medicine in 2020 found that patients with moderate to severe ARDS who received early treatment with extracorporeal membrane oxygenation (ECMO) had a lower risk of death than those who received conventional mechanical ventilation.
2. A study published in the American Journal of Respiratory and Critical Care Medicine in 2019 found that patients with ARDS who received a combination of vitamin C, thiamine, and corticosteroids had lower mortality rates than those who received standard care.
3. A study published in the Journal of the American Medical Association in 2018 found that a conservative fluid management strategy (i.e., limiting the amount of fluid given to patients) was associated with lower mortality rates in patients with ARDS.
4. A study published in Critical Care Medicine in 2017 found that patients with ARDS who received neuromuscular blockers (medications that relax the muscles) had a lower risk of death than those who did not receive this treatment.
5. A study published in the Journal of Critical Care in 2016 found that patients with Acute Respiratory Distress Syndrome who received high-frequency oscillatory ventilation (a type of mechanical ventilation) had similar outcomes to those who received conventional mechanical ventilation.

These studies, among many others, provide valuable insights into the diagnosis and treatment of Acute Respiratory Distress Syndrome and may help improve outcomes for patients with this condition.

Check out Ultimate USMLE Step 1 Study Notes.